Pharmacokinetic and Pharmacodynamic Insights into Vaitarana Basti: An HPTLC-Based Interpretation with Clinical Validation

Abstract

Vaitarana Basti is a classical medicated enema indicated in Amavata (rheumatoid arthritis) and
other Vata-Kapha dominated disorders, yet its behavior in terms of modern pharmacokinetics and
pharmacodynamics has remained largely theoretical. In the present work, a methanolic extract of
Vaitarana Basti (start and end samples) was subjected to high-performance thin-layer chromatography
(HPTLC) on silica gel 60 F₂₅₄ plates, with densitometric scanning at 254 nm and 366 nm. Distinct Rf
bands were observed in both UV ranges, which were tentatively correlated with phenolic acids,
flavonoids, lignans, coumarins, sterols and fatty acid fractions derived mainly from Tamarindus indica
pulp and Sesamum indicum oil [1][2][3][4].
On the basis of published pharmacology of these phytochemical classes and available
experimental data on medicated enemas, a composite picture emerges: phenolic and flavonoid
components likely undergo partial systemic absorption through the rectal mucosa, while lipophilic
lignans and fatty acids contribute to local mucosal protection, modulation of inflammatory mediators
and improved penetration of co-constituents [5][6][7][8]. These findings offer a mechanistic bridge
between traditional Vaitarana Basti indications and contemporary concepts of drug disposition and
tissue-level action. Clinical validation was demonstrated through a case of seropositive rheumatoid
arthritis showing 69.7% reduction in CRP levels and 50% reduction in pain scores following 8-day
Karma Basti protocol [9].